Cimini, A.; Ricci, M.; Russo, F.; Egidi, M.; Calabria, F.; Bagnato, A.; Schillaci, O.; Chiaravalloti, A.
Peptide Receptor Radionuclide Therapy and Primary Brain Tumors: An Overview. Pharmaceuticals 2021, 14, 872.
https://doi.org/10.3390/ph14090872
AMA Style
Cimini A, Ricci M, Russo F, Egidi M, Calabria F, Bagnato A, Schillaci O, Chiaravalloti A.
Peptide Receptor Radionuclide Therapy and Primary Brain Tumors: An Overview. Pharmaceuticals. 2021; 14(9):872.
https://doi.org/10.3390/ph14090872
Chicago/Turabian Style
Cimini, Andrea, Maria Ricci, Francesca Russo, Martina Egidi, Ferdinando Calabria, Antonio Bagnato, Orazio Schillaci, and Agostino Chiaravalloti.
2021. "Peptide Receptor Radionuclide Therapy and Primary Brain Tumors: An Overview" Pharmaceuticals 14, no. 9: 872.
https://doi.org/10.3390/ph14090872
APA Style
Cimini, A., Ricci, M., Russo, F., Egidi, M., Calabria, F., Bagnato, A., Schillaci, O., & Chiaravalloti, A.
(2021). Peptide Receptor Radionuclide Therapy and Primary Brain Tumors: An Overview. Pharmaceuticals, 14(9), 872.
https://doi.org/10.3390/ph14090872